BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1162 related articles for article (PubMed ID: 33560728)

  • 1. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
    Boyarsky BJ; Ou MT; Greenberg RS; Teles AT; Werbel WA; Avery RK; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 May; 105(5):e56-e57. PubMed ID: 33560728
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
    Kamar N; Abravanel F; Marion O; Romieu-Mourez R; Couat C; Del Bello A; Izopet J
    JAMA Netw Open; 2021 Nov; 4(11):e2136030. PubMed ID: 34817587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series.
    Chang A; Alejo JL; Abedon AT; Mitchell J; Chiang TP; Boyarsky BJ; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 Feb; 106(2):e161-e162. PubMed ID: 34789691
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Marion O; Del Bello A; Abravanel F; Couat C; Faguer S; Esposito L; Hebral AL; Izopet J; Kamar N
    Ann Intern Med; 2021 Sep; 174(9):1336-1338. PubMed ID: 34029487
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
    Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients.
    Williams SV; Whitaker HJ; Mumford L; Callaghan C; Curtis RMK; Stowe J; Kirsebom F; Thomas J; Ushiro-Lumb I; Ravanan R; Lopez-Bernal J
    Transplantation; 2022 Jun; 106(6):e310-e311. PubMed ID: 35283455
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review.
    Villavicencio A; Ebisu Y; Raja M; Sanchez-Covarrubias AP; Reynolds JM; Natori Y
    Transpl Infect Dis; 2022 Dec; 24(6):e13936. PubMed ID: 36067062
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    Boyarsky BJ; Werbel WA; Avery RK; Tobian AAR; Massie AB; Segev DL; Garonzik-Wang JM
    JAMA; 2021 May; 325(17):1784-1786. PubMed ID: 33720292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
    Cao J; Liu X; Muthukumar A; Gagan J; Jones P; Zu Y
    Clin Chem; 2021 Dec; 68(1):251-253. PubMed ID: 34358295
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroconversions After Withdrawal From Mycophenolate Mofetil in Solid Organ Transplant Recipients Without a Third Dose of BNT162b2 mRNA Coronavirus Disease 2019 Vaccine: A Case Series.
    Morishita T; Sakai A; Matsunami H
    Transplantation; 2022 Apr; 106(4):e238-e239. PubMed ID: 35030156
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccination in our transplant recipients: The time is now.
    Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
    J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.
    Qin CX; Moore LW; Anjan S; Rahamimov R; Sifri CD; Ali NM; Morales MK; Tsapepas DS; Basic-Jukic N; Miller RA; van Duin D; Santella RN; Wadei HM; Shah PD; Gage N; Malinis M; Aslam S; Todesco E; Werbel WA; Avery RK; Segev DL
    Transplantation; 2021 Nov; 105(11):e265-e266. PubMed ID: 34310531
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.
    Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; McAteer J; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Mogul DB
    Am J Transplant; 2022 Oct; 22(10):2481-2483. PubMed ID: 35510786
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients.
    Del Bello A; Abravanel F; Marion O; Couat C; Esposito L; Lavayssière L; Izopet J; Kamar N
    Am J Transplant; 2022 Jan; 22(1):322-323. PubMed ID: 34331842
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
    Wadei HM; Gonwa TA; Leoni JC; Shah SZ; Aslam N; Speicher LL
    Am J Transplant; 2021 Oct; 21(10):3496-3499. PubMed ID: 33890410
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients.
    Radcliffe C; Azar MM; Cohen E; Tucker M; Grubaugh ND; Malinis M
    Clin Transplant; 2022 Mar; 36(3):e14601. PubMed ID: 35064939
    [No Abstract]   [Full Text] [Related]  

  • 18. Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    Abbasi J
    JAMA; 2022 Apr; 327(14):1323. PubMed ID: 35412579
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy.
    Ison MG; Avery R; Blumberg E; Chin-Hong P; Halasa N; Kaul D; Pergam S; Theodoropoulos NM; Wolfe CR
    Transplantation; 2021 Oct; 105(10):e131-e132. PubMed ID: 33724250
    [No Abstract]   [Full Text] [Related]  

  • 20. Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida.
    Anjan S; Natori Y; Fernandez Betances AA; Agritelley MS; Mattiazzi A; Arosemena L; Andrews DM; Simkins J; Guerra G; Abbo LM
    Transplantation; 2021 Oct; 105(10):e139-e141. PubMed ID: 34319928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 59.